Unlocking the potential of fondaparinux: guideline for optimal usage and clinical suggestions (2023)

• Egile Nagusiak: Qinan Yin (Egilea), Lizhu Han (Egilea), Yin Wang (Egilea), Fengjiao Kang (Egilea), Fengqun Cai (Egilea), Liuyun Wu (Egilea), Xingyue Zheng (Egilea), Lian Li (Egilea), Li e Dong (Egilea), Limei Dong (Egilea), Shuhong Liang (Egilea), Min Chen (Egilea), Yong Yang (Egilea), Yuan Bian (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2024-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: Thromboembolic disease is associated with a high rate of disability or death and gravely jeopardizes people's health and places considerable financial pressure on society. The primary treatment for thromboembolic illness is anticoagulant medication. Fondaparinux, a parenteral antico...